A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Changzhou National High-Tech Zone Holds Groundbreaking Ceremony: 70 New Production and Service Facilities to be Built This Year

Changzhou National High-Tech Zone notes construction is planned to start in 2021. The 70 projects represent a total investment of US$8.9 billion, of which, US$3.3 billion is expected to be made this year.

The projects include 47 manufacturing facilities with a total investment of US$4.6 billion, of which US$1.6 billion is earmarked for 2021. Emerging and specialized sectors account for more than 80% of what will be produced at the new facilities.

The projects are comprised of 17 at the municipal level, 51 at the district level and 2 categorized as key in supporting the transportation infrastructure. Sectors covered by the new projects include smart energy, new materials, electric vehicles, core auto parts, new medicines and medical devices, and next-generation information technology, as well as modern service sectors providing science and innovation platforms. The facilities are aimed at improving the ecological environment, enhancing industrial capacity and improving people’s livelihoods.

The event was held on the grounds where the Phase II project of Intersurgical Medical Device’s plant will be built. Officials from ten sub-districts gave short presentations on the number, value and structure of the investment projects in their respective jurisdictions.

Intersurgical Medical Device (Changzhou) Co., Ltd. is a wholly-owned subsidiary of Intersurgical, the largest manufacturer of respiratory and anesthesia medical devices in Europe. In 2014, the company invested in its Phase I project in the Life and Health Industrial Park of Changzhou National High-Tech Zone. The Phase II project has a total investment of UKP 36 million (approx. US$49 million), and a projected annual production capacity of 110 million units of medical equipment such as respiratory therapy devices, respiratory filtration devices and anesthesia masks, as well as 100 sets of trimming molds.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy